COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Critical Illness Recovery Navigator for Alcohol

Not Applicable

Terminated

Conditions: Alcohol Use Disorder (AUD)

Interventions: Behavioral: Recovery Navigator on an as needed basis up to 6 months
Behavioral: Recovery Navigator prior to hospital discharge
Other: No interaction with Recovery Navigator

First Posted Date: 2017-02-23

Last Posted Date: 2019-11-21

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 47

Registration Number: NCT03059082

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: Tucatinib in Combination with Palbociclib and Letrozole

First Posted Date: 2017-02-15

Last Posted Date: 2023-11-13

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 42

Registration Number: NCT03054363

Locations: 🇺🇸
University of Texas Health Science Center San Antonio, San Antonio, Texas, United States
🇺🇸
University of Arizona, Tucson, Arizona, United States
🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

and more 3 locations

Medical Marijuana in the Pediatric Central Nervous System Tumor Population

Completed

Conditions: Spinal Tumor
Brain Tumor
Central Nervous System Tumor

First Posted Date: 2017-02-14

Last Posted Date: 2024-08-29

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 19

Registration Number: NCT03052738

Locations: 🇺🇸
Chilsdren's Hospital Colorado, Aurora, Colorado, United States

CKDu in Sugarcane Workers in Guatemala

Not Applicable

Completed

Conditions: Chronic Kidney Disease

Interventions: Behavioral: Education, Incentives and Feedback

First Posted Date: 2017-02-10

Last Posted Date: 2021-06-23

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 531

Registration Number: NCT03049527

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
🇬🇹
Panteleon, Escuintla, Guatemala

NMT for Parkinson's Disease

Not Applicable

Recruiting

Conditions: Parkinson Disease

Interventions: Other: Neurologic Music Therapy
Other: Music Supported Therapy
Other: Occupational Therapy

First Posted Date: 2017-02-09

Last Posted Date: 2024-01-03

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 100

Registration Number: NCT03049033

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy

Recruiting

Conditions: ALK Gene Mutation
EGFR Gene Mutation
ROSE Cluster 1
Non-Small Cell Carcinoma of Lung, TNM Stage 4
BRAF V600E
Non-Small Cell Lung Cancer

First Posted Date: 2017-02-03

Last Posted Date: 2025-02-06

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 100

Registration Number: NCT03042221

Locations: 🇺🇸
University of Colorado, Cancer Center, Aurora, Colorado, United States

Post-Prandial Liver Glucose Metabolism in PCOS

Completed

Conditions: Obesity
Polycystic Ovarian Syndrome
Hepatic Steatosis

Interventions: Diagnostic Test: oral glucose tolerance test
Diagnostic Test: MRI of liver

First Posted Date: 2017-02-02

Last Posted Date: 2024-04-17

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 19

Registration Number: NCT03041129

Locations: 🇺🇸
University of Colorado Anshutz Medical Campus/Children's Hospital Colorado, Aurora, Colorado, United States

Intervention to Reduce Fear of Hypoglycemia and Optimize Type 1 Diabetes Outcomes

Not Applicable

Completed

Conditions: Type1diabetes
Fear of Hypoglycemia

Interventions: Behavioral: Fear of Hypoglycemia
Other: Treatment As Usual

First Posted Date: 2017-02-01

Last Posted Date: 2021-09-16

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 43

Registration Number: NCT03039933

Locations: 🇺🇸
University of Colorado, Denver, Aurora, Colorado, United States

A Study of Durvalumab in Patients With BR PDA Following Neoadjuvant Therapy and Successful Surgical Resection

Phase 2

Withdrawn

Conditions: Pancreatic Cancer

Interventions: Drug: Durvalumab

First Posted Date: 2017-01-31

Last Posted Date: 2020-09-14

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT03038477

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT Population

Completed

Conditions: Hematopoietic Stem Cell Transplantation

Interventions: Device: Continuous Glucose Monitor (CGM)

First Posted Date: 2017-01-31

Last Posted Date: 2024-08-19

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 29

Registration Number: NCT03037671

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy